MarkNtel Advisors, a leading market research and consulting firm, has announced the release of its latest study titled Cancer Gene Panel and Profiling Market Research Report: Forecast (2024–2029). This report provides a detailed assessment of the Cancer Gene Panel and Profiling, covering its evolving dynamics, emerging trends, key growth drivers, major challenges, and competitive landscape.
Designed to guide investors, stakeholders, and business leaders, the research aims to deliver valuable insights for strategic planning, risk assessment, and investment decision-making in the years ahead.
Market Timeline Overview
- Historical Years: 2019–22
- Base Year: 2023
- Forecast Years: 2024–30
This helps businesses identify emerging opportunities, assess market risks, and develop data-driven strategies for long-term success.
Download a FREE PDF Sample of the Report: - https://www.marknteladvisors.com/query/request-sample/cancer-gene-panel-profiling-market.html (Discover the market potential, platform-specific insights, and key industry trends.)
In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Cancer Gene Panel and Profiling Market Outlook
The Global Cancer Gene Panel & Profiling Market is estimated to grow at a CAGR of around 15.5% during the forecast period, i.e., 2024-29. The exponential increase in the incidence of cancer has emerged as a key driver propelling the market growth for cancer gene panels & profiling testing services. For instance, according to the Global Cancer Observatory, in 2022, there were approximately 19.3 million new cases & 10.3 million deaths due to cancer all across the globe. Breast Cancer in females surpassed lung cancer in 2020, thereby becoming the most common type of diagnosed cancer with 11.7% prevalence, followed by lung cancer at 11.4%, colon cancer at 10%, prostate cancer at 7.3%, and stomach cancer at 5.6%.
Cancer Gene Panel and Profiling Market Drivers:
Growing Prevalence of Hereditary Cancer Cases Globally – The escalating prevalence of hereditary cancer occurrences on a global scale has amplified the demand for genetic panels & profiling testing within the market. This has been mainly because the cancer gene panel and profiling services are highly effective & accurate in the detection of hereditary cancer cases.
View Full Report (All Data, In One Place): - https://www.marknteladvisors.com/research-library/cancer-gene-panel-profiling-market.html (Explore in-depth analyses, technological trends, and investment patterns.)
Cancer Gene Panel and Profiling Market Trends:
Rising Advancement in Next-generation Sequencing (NGS) Technology to Boost the Market – Next-generation Sequencing (NGS) is a powerful technique employed to simultaneously analyze multiple genomes, and in recent years, there has been an increasing advancement in this technology. This has been attributed to the growing prevalence of chronic & life-threatening diseases such as cancer, creating a pressing need for rapid & precise testing to guide patient treatment decisions.
Cancer Gene Panel and Profiling Market Segmentation
The study categorizes the Cancer Gene Panel and Profiling into various segments and sub-segments, each analyzed for its size, growth potential, and contribution to the overall industry.
By Technology
- Next-generation Sequencing (NGS)- Market Size & Forecast 2019-2029, USD Million
- Polymerase Chain Reaction(PCR)- Market Size & Forecast 2019-2029, USD Million
- Microarray- Market Size & Forecast 2019-2029, USD Million
- Mass Spectrometry- Market Size & Forecast 2019-2029, USD Million
- Others (Fluorescence in-situ hybridization, Immunohistochemistry, etc.)- Market Size & Forecast 2019-2029, USD Million
By Application
- Oncology Research- Market Size & Forecast 2019-2029, USD Million
- Personalized Medicine- Market Size & Forecast 2019-2029, USD Million
- Drug Development- Market Size & Forecast 2019-2029, USD Million
- Clinical Diagnostics- Market Size & Forecast 2019-2029, USD Million
By Cancer Type
- Breast Cancer- Market Size & Forecast 2019-2029, USD Million
- Lung Cancer- Market Size & Forecast 2019-2029, USD Million
- Prostrate Cancer- Market Size & Forecast 2019-2029, USD Million
- Colorectal Cancer- Market Size & Forecast 2019-2029, USD Million
- Others (Ovarian Cancer, Leukemia, etc.) - Market Size & Forecast 2019-2029, USD Million
By Cell Type
- Germline - Market Size & Forecast 2019-2029, USD Million
- Somatic - Market Size & Forecast 2019-2029, USD Million
By End-User
- Hospital & Clinics- Market Size & Forecast 2019-2029, USD Million
- Research Institutes- Market Size & Forecast 2019-2029, USD Million
- Diagnostic Laboratories- Market Size & Forecast 2019-2029, USD Million
- Pharmaceutical and Biotechnology- Market Size & Forecast 2019-2029, USD Million
Geographical Analysis
The report presents detailed insights into the market’s geographical expansion, highlighting key trends and opportunities across the following geographies:
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific.
Talk to Our Industry Analyst: - https://www.marknteladvisors.com/query/talk-to-our-consultant/cancer-gene-panel-profiling-market.html Get personalized insights into company strategies and regional market dynamics.)
Leading Companies in Cancer Gene Panel and Profiling Market Worldwide: Players, Analysis & Future Outlook
- 10x Genomics, Inc.
- Neo genomics
- Flugent Genetics
- Centogene N.V.
- Geneseeq Technology Inc.
- Variantyx
- Genetron Holdings Limited
- Laboratory Corporation of America® Holdings (LabCorp)
- T. G Molecular
- Bio array Diagnostic genetic
- Biorad laboratories Inc.
- Enzo Lifesciences
- Eurofins Scientific
- Nanostring Technologies
Key Highlights of the Report
- Comprehensive Market Overview: In-depth analysis of market size, share, and forecasts from 2024 to 2029.
- Growth Drivers & Challenges: Clear insights into factors feeling or restraining market expansion.
- Investment & Regulatory Insights: Evaluation of key policies, funding trends, and collaborations influencing industry performance.
- Competitive Landscape: Detailed profiles of leading companies, including product portfolios, business strategies, financials, and recent developments such as mergers & acquisitions.
Analytical Tools: Application of SWOT Analysis, PESTEL Analysis, and Porter’s Five Forces Model to assess competition and external influences
Browse through our flexible pricing plans and choose the package that best fits your business needs whether you require a single-user license, corporate access, or customized insights. Once you select the plan that suits your requirements, you can purchase and instantly access the full report online – https://www.marknteladvisors.com/pricing/cancer-gene-panel-profiling-market.html
Frequently Asked Questions (FAQ)
- What is the projected growth rate of the Cancer Gene Panel and Profiling?
2. What are the major factors driving this market’s growth?
3. Which regions are expected to lead the Cancer Gene Panel and Profiling?
4. Who are the prominent players in the Cancer Gene Panel and Profiling?
5. How is the competition structured in this market?
6. How can I access the full report?
About Us
MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.
Contact Us:
MarkNtel Advisors
Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 87199 99009
Email: sales@marknteladvisors.com
Website: https://www.marknteladvisors.com